Identification of biomarkers and their functions in dasatinib-resistant pancreatic cancer using bioinformatics analysis

Dasatinib is a tyrosine kinase inhibitor, which inhibits tumor proliferation by blocking SRC pathways and is considered as a potential treatment of various epithelial neoplasms, including pancreatic cancer. However, dasatinib efficacy is largely limited due to drug resistance. In the present study,...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Oncol Lett
Autors principals: Wei, Jingsun, Han, Rongbo, Su, Xinyu, Chen, Yuetong, Shi, Junfeng, Cui, Xiaowen, Zhang, Honghong, Gong, Yang, Chu, Xia, Chen, Jinfei
Format: Artigo
Idioma:Inglês
Publicat: D.A. Spandidos 2019
Matèries:
Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6540339/
https://ncbi.nlm.nih.gov/pubmed/31289489
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2019.10281
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars